Dr. Adrienne D. Mishkin, MD, MPH

Dr. Mishkin practices at Columbia University Irving Medical Center in New York, New York.

Dr. Mishkin's NPI, 1245545920, was assigned on August 18, 2010. Dr. Mishkin graduated from Tulane University School of Medicine in 2009. Dr. Mishkin holds New York license 259797.

Dr. Mishkin's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Mishkin's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Mishkin is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mishkin practices. Vendor and product names are available with a free account.

Psychiatry is Dr. Mishkin's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Mishkin is licensed in New York.

CMS data shows 126 Medicare services from Dr. Mishkin across 2 procedure codes in 2024, for 20 Medicare patients. Medicare paid $10,835 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 20 Medicare patients who saw Dr. Mishkin in 2024. The largest group is 85 and over, with 0 patients. 75% of them have high blood pressure, and 60% have high cholesterol. Their average risk score is 3.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mishkin's median patient age at 60, with 33% women.

In 2024, Dr. Mishkin wrote 25 Medicare Part D claims. 100% of them were for generic drugs. They cover 3 drugs, with $1,863 in total drug cost. In 2022, CMS named 105 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Mishkin for performance year 2024, reported through an alternative payment model (APM). Dr. Mishkin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mishkin as offering telehealth.

Dmand AI links 19 papers to Dr. Mishkin, published from 2017 to 2023. 2023 was the busiest year, with 4. The most frequent topics are Anemia, Sickle Cell, Hematopoietic Stem Cell Transplantation and Psychiatry. Dr. Mishkin has published most often in J Acad Consult Liaison Psychiatry. Dr. Mishkin's most frequent co-authors are Stephanie Garling Cheung, MD, Markus Yashavant Mapara, MD and Eric Karl Gustafson, MD.

CMS Open Payments shows 1 general payment to Dr. Mishkin from 1 drug or device company in 2023. Food and beverage make up the largest share, 100% of the total. Alexion Pharmaceuticals, Inc. paid the most, $22.

Dr. Mishkin graduated from Tulane University School of Medicine in 2009.